Filter Results
:
(85)
Show Results For
-
All HBS Web
(174)
- People (1)
- News (71)
- Research (85)
- Events (1)
- Multimedia (9)
- Faculty Publications (52)
Show Results For
-
All HBS Web
(174)
- People (1)
- News (71)
- Research (85)
- Events (1)
- Multimedia (9)
- Faculty Publications (52)
Sort by
- 24 Jul 2018
- First Look
New Research and Ideas, July 24, 2018
2017, Jason Blum, the founder and chief executive officer of film and television production company Blumhouse Productions, has another blockbuster on his hands with the movie Get Out, produced for just $4.5 million. Remarkable returns for...
View Details
Keywords:
Dina Gerdeman
- November 2004 (Revised May 2005)
- Case
Marvel Enterprises, Inc.
By: Anita Elberse
The management team of Marvel Enterprises, known for its universe of superhero characters that includes Spider-Man, the Hulk, and X-Men, must reevaluate its marketing strategy. In June 2004, only six years after the company emerged from bankruptcy, Marvel has amassed a...
View Details
Keywords:
Intellectual Property;
Business Model;
Brands and Branding;
Marketing Strategy;
Opportunities;
Growth and Development Strategy;
Rights;
Entertainment and Recreation Industry
Elberse, Anita. "Marvel Enterprises, Inc." Harvard Business School Case 505-001, November 2004. (Revised May 2005.)
- October 1997 (Revised September 2003)
- Case
Eli Lilly and Company: Drug Development Strategy (A)
By: Stefan H. Thomke, Ashok Nimgade and Paul Pospisil
Describes how Eli Lilly and Co. tries to accelerate its new drug development process with the aid of "combinatorial chemistry"--a rapidly emerging and revolutionary approach to preclinical drug discovery. The product manager of a potential blockbuster migraine drug...
View Details
Keywords:
Chemicals;
Finance;
Innovation and Invention;
Time Management;
Markets;
Product Development;
Organizations;
Business Processes;
Problems and Challenges;
Business and Stakeholder Relations;
Competition;
Pharmaceutical Industry
Thomke, Stefan H., Ashok Nimgade, and Paul Pospisil. "Eli Lilly and Company: Drug Development Strategy (A)." Harvard Business School Case 698-010, October 1997. (Revised September 2003.)
- 08 Jul 2008
- First Look
First Look: July 8, 2008
and practice are discussed. Download the revised paper: http://www.hbs.edu/research/pdf/08-080.pdf PublicationsShould You Invest in the Long Tail? Author:Anita Elberse Periodical:HBS Centennial Issue. Harvard Business Review 86, nos. 7/8 (July-August 2008): 88-96...
View Details
Keywords:
Martha Lagace
- 23 Oct 2006
- Research & Ideas
Will the “Long Tail” Work for Hollywood?
than a Blockbuster store, stocking a limited number of popular movies? Intrigued with these questions, HBS assistant professor Anita Elberse and associate professor Felix Oberholzer-Gee analyzed the distribution of revenues in the U.S....
View Details
- Teaching Interest
The Business of Entertainment, Media, and Sports (Executive Education)
By: Anita Elberse
In the business of entertainment, digital technologies are dramatically disrupting the way products are developed, marketed, and distributed. As a result of this paradigm shift, entertainment executives and content producers are challenged to effectively allocate...
View Details
- March 2017 (Revised December 2018)
- Case
Reawakening the Magic: Bob Iger and the Walt Disney Company
By: David Collis and Ashley Hartman
Mickey Mouse, Snow White, and Buzz Lightyear strolled down Main Street at the grand opening of Hong Kong Disney in the fall of 2005, pausing to snap selfies with enthusiastic children in Mickey Mouse ears. Bob Iger, newly appointed CEO of The Walt Disney Company,...
View Details
Keywords:
Franchise Management;
Brand Management;
Culture Change;
Business Units;
Acquisition Strategy;
Technological Change;
Disney;
ESPN;
Cord-cutting;
Bob Iger;
Strategy;
Corporate Strategy;
Competitive Advantage;
Diversification;
Integration;
Media;
Media and Broadcasting Industry;
Entertainment and Recreation Industry;
Consumer Products Industry
Collis, David, and Ashley Hartman. "Reawakening the Magic: Bob Iger and the Walt Disney Company." Harvard Business School Case 717-483, March 2017. (Revised December 2018.)
- March 2018 (Revised January 2019)
- Case
Gilead Mexico
By: Michael Chu and V. Kasturi Rangan
With a breakthrough cure for Hepatitis C listing in the U.S. at $1,000/pill, Gilead must now solve the issue of making it available to patients across the world, much as it did for its blockbuster HIV/AIDS antiretrovirals. For Erik Musalem, the new general manager of...
View Details
Chu, Michael, and V. Kasturi Rangan. "Gilead Mexico." Harvard Business School Case 318-111, March 2018. (Revised January 2019.)
- January 2011 (Revised January 2011)
- Case
Marvel Enterprises, Inc. (Abridged)
By: Anita Elberse
The management team of Marvel Enterprises, known for its universe of superhero characters that includes Spider-Man, the Hulk, and X-Men, must reevaluate its marketing strategy. In June 2004, only six years after the company emerged from bankruptcy, Marvel has amassed a...
View Details
Keywords:
Business Model;
Intellectual Property;
Rights;
Growth and Development Strategy;
Brands and Branding;
Marketing Strategy;
Entertainment and Recreation Industry
Elberse, Anita. "Marvel Enterprises, Inc. (Abridged)." Harvard Business School Case 511-097, January 2011. (Revised January 2011.)
- June 2004
- Case
Aventis SA (A): Planning for a Merger
By: Joshua D. Margolis and Carin-Isabel Knoop
Eight executives at Hoechst and Rhone-Poulenc must make four crucial decisions on the eve of merging their companies to become Aventis--what would become the world's third largest pharmaceutical firm. In addition to formulating a vision and strategy, the two firms must...
View Details
Keywords:
Problems and Challenges;
Mergers and Acquisitions;
Horizontal Integration;
Organizational Design;
Organizational Culture;
Pharmaceutical Industry;
United States
Margolis, Joshua D., and Carin-Isabel Knoop. "Aventis SA (A): Planning for a Merger." Harvard Business School Case 404-003, June 2004.
- 28 Jun 2007
- Working Paper Summaries
Film Rentals and Procrastination: A Study of Intertemporal Reversals in Preferences and Intrapersonal Conflict
- 2008
- Chapter
Where is the Pharmacy to the World? Pharmaceutical Industry Location and International Regulatory Variation
By: Arthur A. Daemmrich
A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based organizations have assumed greater...
View Details
Keywords:
Geographic Location;
Governing Rules, Regulations, and Reforms;
Health Testing and Trials;
Demand and Consumers;
Pharmaceutical Industry;
European Union;
Germany;
United States
Daemmrich, Arthur A. "Where is the Pharmacy to the World? Pharmaceutical Industry Location and International Regulatory Variation." Chap. 16 in Ways of Regulating: Therapeutic Agents between Plants, Shops, and Consulting Rooms. Vol. 363, edited by Jean Paul Gaudillière and Volker Hess, 271–290. Berlin, Germany: Max-Planck-Institut für Wissenschaftsgeschichte, 2008.
- 2009
- Working Paper
Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location
By: Arthur Daemmrich
A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based organizations have assumed greater...
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Health Disorders;
Health Testing and Trials;
Power and Influence;
Competitive Strategy;
Pharmaceutical Industry;
European Union;
Germany;
United States
Daemmrich, Arthur. "Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location." Harvard Business School Working Paper, No. 09-118, April 2009.
- 08 Feb 2011
- First Look
First Look: Feb. 8
just a fluke? Was Marvel's success dependent on a limited set of blockbuster characters, most notably Spider-Man, and should Marvel continue to capitalize on those characters? Or was it time to seek growth in a larger set of lesser known...
View Details
Keywords:
Sean Silverthorne
- 10 Jul 2007
- Working Paper Summaries
Platform Envelopment
- 10 Oct 2007
- First Look
First Look: First Look: October 10
Hamermesh, Faculty Chair of the Harvard Business Healthcare Initiative, discuss the barriers to personalized medicine and suggest ways to overcome them. The blockbuster model for developing drugs, the authors point out, is still what most...
View Details
Keywords:
Martha Lagace
- 28 Jun 2011
- First Look
First Look: June 28
PublicationsManager-Specific Effects on Earnings Guidance: An Analysis of Top Executive Turnovers Authors:Francois Brochet, Lucile Faurel, and Sarah McVay Publication:Journal of Accounting Research (forthcoming) Abstract We investigate how managers contribute to the...
View Details
Keywords:
Sean Silverthorne
- 09 May 2012
- Research & Ideas
Clayton Christensen’s “How Will You Measure Your Life?”
The Trap Of Marginal Thinking In the late 1990s, Blockbuster dominated the movie rental industry in the United States. It had stores all over the country, a significant size advantage, and what appeared to be a stranglehold on the market....
View Details
- August 2007 (Revised November 2010)
- Case
Grand Central Publishing
By: Anita Elberse
In April 2007, Grand Central's publisher Jamie Raab and editor Karen Kosztolnyik were involved in a frantic bidding war for a proposed book on the life of cat Dewey, billed as the feline answer to the best-selling "Marley & Me: Life and Love with the World's Worst...
View Details
Elberse, Anita. "Grand Central Publishing." Harvard Business School Case 508-036, August 2007. (Revised November 2010.)
- July 2006
- Background Note
Out of Frame: The Coming Digital Disruption of Hollywood
By: Stephen P. Bradley, Brian DeLacey and Reed Martin
The record opening of the Pirates of the Caribbean: Dead Man's Chest, starring Johnny Depp, had finally provided the industry with incontrovertible proof that it was still possible to draw massive audiences to movie theaters. Grossing $136 million during its opening...
View Details